BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
85 hedge funds and large institutions have $17.1M invested in bluebird bio in 2025 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
6% more funds holding
Funds holding: 80 → 85 (+5)
28% less capital invested
Capital invested by funds: $23.7M → $17.1M (-$6.55M)
38% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 24
Holders
85
Holding in Top 10
2
Calls
$23.8M
Puts
$7M
Top Buyers
| 1 | +$1.95M | |
| 2 | +$732K | |
| 3 | +$679K | |
| 4 |
EPM
Equitec Proprietary Markets
Chicago,
Illinois
|
+$540K |
| 5 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$397K |
Top Sellers
| 1 | -$680K | |
| 2 | -$632K | |
| 3 | -$409K | |
| 4 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
-$407K |
| 5 |
Jane Street
New York
|
-$336K |
